Fig. 2From: Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenomeQ-Q plots for a cisplatin-based chemotherapy (CBCT) model, methylation β value as the dependent and CBCT as the independent variable, adjusted for smoking, age, testosterone, and cell count. b Metabolic syndrome (MetS) model, MetS as the dependent and methylation β value as the independent variable, adjusted for CBCT, smoking and ageBack to article page